These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38423595)
21. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909 [TBL] [Abstract][Full Text] [Related]
22. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma. Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964 [TBL] [Abstract][Full Text] [Related]
23. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Arai E; Ushijima S; Tsuda H; Fujimoto H; Hosoda F; Shibata T; Kondo T; Imoto I; Inazawa J; Hirohashi S; Kanai Y Clin Cancer Res; 2008 Sep; 14(17):5531-9. PubMed ID: 18765545 [TBL] [Abstract][Full Text] [Related]
24. Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Tennenbaum DM; Manley BJ; Zabor E; Becerra MF; Carlo MI; Casuscelli J; Redzematovic A; Khan N; Arcila ME; Voss MH; Feldman DR; Motzer RJ; Benfante NE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA Urol Oncol; 2017 Aug; 35(8):532.e7-532.e13. PubMed ID: 28408295 [TBL] [Abstract][Full Text] [Related]
25. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma. Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S Front Immunol; 2022; 13():890150. PubMed ID: 35686121 [TBL] [Abstract][Full Text] [Related]
26. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Nickerson ML; Jaeger E; Shi Y; Durocher JA; Mahurkar S; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Mukeria A; Holcatova I; Schmidt LS; Toro JR; Karami S; Hung R; Gerard GF; Linehan WM; Merino M; Zbar B; Boffetta P; Brennan P; Rothman N; Chow WH; Waldman FM; Moore LE Clin Cancer Res; 2008 Aug; 14(15):4726-34. PubMed ID: 18676741 [TBL] [Abstract][Full Text] [Related]
27. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810 [TBL] [Abstract][Full Text] [Related]
28. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3. Ling ZN; Hong LL; Wu J; Ling ZQ Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma. Zhang H; Liu Y; Wang B; Wang C BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015 [TBL] [Abstract][Full Text] [Related]
30. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma. Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693 [TBL] [Abstract][Full Text] [Related]
31. The genomic and epigenomic evolutionary history of papillary renal cell carcinomas. Zhu B; Poeta ML; Costantini M; Zhang T; Shi J; Sentinelli S; Zhao W; Pompeo V; Cardelli M; Alexandrov BS; Otlu B; Hua X; Jones K; Brodie S; Dabrowska ME; Toro JR; Yeager M; Wang M; Hicks B; Alexandrov LB; Brown KM; Wedge DC; Chanock S; Fazio VM; Gallucci M; Landi MT Nat Commun; 2020 Jun; 11(1):3096. PubMed ID: 32555180 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma. Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355 [TBL] [Abstract][Full Text] [Related]
33. Relationship between visceral adipose tissue and genetic mutations (VHL and KDM5C) in clear cell renal cell carcinoma. Greco F; Mallio CA Radiol Med; 2021 May; 126(5):645-651. PubMed ID: 33400184 [TBL] [Abstract][Full Text] [Related]
34. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
35. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma. Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679 [TBL] [Abstract][Full Text] [Related]
36. Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression. Quiroga-Garza G; Piña-Oviedo S; Cuevas-Ocampo K; Goldfarb R; Schwartz MR; Ayala AG; Monzon FA Diagn Pathol; 2012 Feb; 7():21. PubMed ID: 22369180 [TBL] [Abstract][Full Text] [Related]
37. A novel highly frequent single‑nucleotide polymorphism site of cadherin 23 in clear cell renal cell carcinoma with sarcomatoid differentiation based on whole exome sequencing. Yu W; Wang X; Wang Y; Jiang Y; Zhang W; Shi H; Li Y Oncol Rep; 2020 Aug; 44(2):735-746. PubMed ID: 32468012 [TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. Su Y; Zhang T; Lu J; Qian L; Fei Y; Zhang L; Fan S; Zhou J; Tang J; Chen H; Liang C Cells; 2023 Jan; 12(1):. PubMed ID: 36611973 [TBL] [Abstract][Full Text] [Related]
40. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas. Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]